- Home
- FTFT vs ALZN Comparison
FTFT vs ALZN Comparison
Compare FTFT & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- ALZN
- Stock Information
- Founded
- FTFT N/A
- ALZN 2016
- Country
- FTFT United States
- ALZN United States
- Employees
- FTFT N/A
- ALZN N/A
- Industry
- FTFT Business Services
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- FTFT Consumer Discretionary
- ALZN Health Care
- Exchange
- FTFT Nasdaq
- ALZN Nasdaq
- Market Cap
- FTFT 8.7M
- ALZN 7.0M
- IPO Year
- FTFT N/A
- ALZN 2021
- Fundamental
- Price
- FTFT $0.30
- ALZN $1.11
- Analyst Decision
- FTFT
- ALZN Strong Buy
- Analyst Count
- FTFT 0
- ALZN 1
- Target Price
- FTFT N/A
- ALZN $32.00
- AVG Volume (30 Days)
- FTFT 456.9K
- ALZN 174.2K
- Earning Date
- FTFT 11-19-2024
- ALZN 12-31-2024
- Dividend Yield
- FTFT N/A
- ALZN N/A
- EPS Growth
- FTFT N/A
- ALZN N/A
- EPS
- FTFT N/A
- ALZN N/A
- Revenue
- FTFT $18,543,659.00
- ALZN N/A
- Revenue This Year
- FTFT N/A
- ALZN N/A
- Revenue Next Year
- FTFT N/A
- ALZN N/A
- P/E Ratio
- FTFT N/A
- ALZN N/A
- Revenue Growth
- FTFT N/A
- ALZN N/A
- 52 Week Low
- FTFT $0.26
- ALZN $1.06
- 52 Week High
- FTFT $2.60
- ALZN $15.06
- Technical
- Relative Strength Index (RSI)
- FTFT 42.24
- ALZN 34.55
- Support Level
- FTFT $0.26
- ALZN $1.16
- Resistance Level
- FTFT $0.36
- ALZN $1.33
- Average True Range (ATR)
- FTFT 0.05
- ALZN 0.09
- MACD
- FTFT -0.01
- ALZN 0.01
- Stochastic Oscillator
- FTFT 24.35
- ALZN 17.86
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.